Skip to main content

Table 1 Selected characteristics of studies in the meta-analysis

From: The role of postmastectomy radiation in patients with ypN0 breast cancer after neoadjuvant chemotherapy: a meta-analysis

Study

Country

Year

No. of patients

Patholo-gical stage

Type of surgery

NAC

Outcome

Median follow up (Months)

Huang

American

2004

676

II -IV

Mastectomy

A/T,VACP

LRR,

69

McGuire

American

2007

106

I-III

Mastectomy

A/T

LRR, OS

62

Scodan

France

2010

134

II-III

Mastectomy

A/T

LRR, DFS, OS

91

Nagar

American

2011

162

II

Mastectomy

A/T

LRR

75

Bae

Korean

2012

98

0- III

Mastectomy

NR

LRR, DFS, OS

42

Shim

Korea

2013

151

II-III

Mastectomy

A/T

LRR, OS, DFS

59

Liu

American

2015

1560

II -III

Mastectomy

NR

OS

56

Rusthove-n

American

2016

3040

II -III

Mastectomy

NR

OS

41

Kantor

American

2016

8321

I-III

Mastectomy

NR

OS

69

Qinlin

China

2017

185

II - III

Mastectomy

A/T

LRR, DFS, OS

70

Cao

China

2017

88

I-III

Mastectomy

A/T

LRR, DFS, OS

67

Miyashita

Japan

2019

3226

I-III

Mastectomy

NR

LRR, DDFS, OS

>  60

  1. Abbreviations: NAC Neoadjuvant chemotherapy, A Anthracycline-based chemotherapy, A/T Anthracycline- or taxane- based chemotherapy, NR No report, LRR Local-regional recurrence, DFS Ddisease-free survival, OS Overall survival